AstraZeneca suffers diabetes drug setback for COVID
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
- Next story The best OnePlus phones for 2021
- Previous story Mysterious blackout in Iran threatens to undermine nuclear talks
Explore more
- Discovery and AT&T: How a Huge Media Deal Was Done
An early-morning meeting at a Greenwich Village townhouse, under the watchful eye... - One High School, Five Students Fatally Shot
Five students at a Knoxville, Tenn., high school have been killed in... - University of Texas Faces New Outcry Over Old Song With Minstrel Roots
Many students want “The Eyes of Texas” to go. Wealthy alumni insist... - Russia’s navy is flexing its muscles in one of the world’s smallest seas
- Anti-Olympics campaign gains traction online in Japan
An online petition calling for the Tokyo Olympics to be canceled has... - MLB Raises ALS Awareness With Lou Gehrig Day
Gwen Peterson, who has Lou Gehrig’s Disease, is one of the many... - Covid Vaccine Lag in U.S. South May Lead to Summer Wave of Infections
In 15 states, including Arkansas, the Carolinas, Georgia and Louisiana, about half... - Once-a-week insulin treatment could be game-changing for patients with diabetes
Treating people with Type 2 diabetes with a new once-a-week injectable insulin... - Lab reveals how an oral antiviral drug confuses the replication machinery of SARS-CoV-2
A University of Alberta virology lab has uncovered how an oral antiviral... - Aphantasia explained: Some people can’t form mental pictures
How many times have you watched a book adaptation on film or...